NCT02037061

Brief Summary

This is a randomized controlled trial to determine if intraoperative local analgesia administered at the level of the sacrospinous ligament can lessen the gluteal pain felt by patients postoperatively after SSL colpopexy. Hypothesis: Local analgesia administered at the level of the sacrospinous ligament can lessen the gluteal pain felt by patients postoperatively after SSL colpopexy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Mar 2014

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 15, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

August 14, 2019

Completed
Last Updated

August 14, 2019

Status Verified

July 1, 2019

Enrollment Period

2.3 years

First QC Date

January 14, 2014

Results QC Date

May 5, 2017

Last Update Submit

July 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Gluteal Pain

    Pain measured using a pain numeric rating scale from 0 to 10 (0=no pain, 10= worst pain imaginable)

    6-weeks

Secondary Outcomes (2)

  • Need for Intervention for Postoperative Pain

    6-weeks

  • Overall Pain Beyond Day of Discharge

    6 weeks

Study Arms (2)

normal saline

PLACEBO COMPARATOR

Intraoperatively the patient will receive 10ml of normal saline injected into the sacrospinous ligament.

Other: Normal Saline

bupivacaine

ACTIVE COMPARATOR

Intraoperatively the patient will receive 10 ml of bupivacaine injected into the sacrospinous ligament.

Drug: Bupivacaine

Interventions

Intraoperatively the patient will receive 10ml of bupivacaine injected into the sacrospinous ligament.

bupivacaine
normal saline

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18, who are to undergo sacrospinous ligament colpopexy for vaginal apex prolapse after hysterectomy
  • Other concomitant prolapse and anti-incontinence procedures (e.g., anterior colporrhaphy, paravaginal defect repair, posterior colporrhaphy, or mid-urethral sling procedures) will be performed at the primary surgeon's discretion

You may not qualify if:

  • Inability to comprehend written and/or spoken English
  • Inability to provide informed consent
  • Need for concomitant surgeries not related to pelvic organ prolapse or incontinence
  • Chronic pain conditions (e.g., fibromyalgia, myositis, myofascial pain syndrome)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Related Publications (1)

  • Ferrando CA, Walters MD. A randomized double-blind placebo-controlled trial on the effect of local analgesia on postoperative gluteal pain in patients undergoing sacrospinous ligament colpopexy. Am J Obstet Gynecol. 2018 Jun;218(6):599.e1-599.e8. doi: 10.1016/j.ajog.2018.03.033. Epub 2018 Mar 31.

MeSH Terms

Conditions

Pain

Interventions

BupivacaineSaline Solution

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Results Point of Contact

Title
Dr. Cecile Unger
Organization
Cleveland Clinic

Study Officials

  • Cecile Unger, M.D.

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2014

First Posted

January 15, 2014

Study Start

March 1, 2014

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

August 14, 2019

Results First Posted

August 14, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations